Daiichi Sankyo Company Profile

Aggregated data from the web about Daiichi Sankyo

Company Name	Daiichi Sankyo
Website
Snippet	The Daiichi Sankyo group is actively engaged in various measures and initiatives such as, but not limited to, contributing to vaccination and drug research and development, ensuring a continuous supply of Daiichi Sankyo group company products, and providing disaster relief support.
Type	Public KK
Founded	2005
Revenue	$ 9.028 billion USD (FY 2019) (? 981.8 billion JPY) (FY 2019)
Website	http://www.daiichisankyo.com
Industry	Pharmaceutical
Products	Medical equipment, Pharmaceutical products, Veterinary medicines
Traded as	TYO: 4568TOPIX Large 70 ComponentTOPIX 100 ComponentNikkei 225 Component
Key people	Sunao Manabe (Representative Director, and President)[1][2], Ken Keller (President and CEO, Daiichi Sankyo, Inc.)[3]
Net income	$ 1.276 billion USD (FY 2019) (? 138.8 billion JPY) (FY 2019)
Native name	第一叁共株式会社
Headquarters	Daiichi Sankyo Building A/B 3-5-1, Nihonbashi-honcho, Chūō-ku, Tokyo 103-8426, Japan
Predecessors	Daiichi Pharmaceutical Company, Sankyo Company
Romanized name	Daiichi Sankyō kabushiki gaisha
Number of employees	15,348 (as of March 2020)

Daiichi Sankyo is part of the Japan company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that 暗网禁区 Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.